{"id":3894,"date":"2018-10-16T11:22:26","date_gmt":"2018-10-16T09:22:26","guid":{"rendered":"http:\/\/www.seventure.fr\/wp-content\/uploads\/2018\/10\/4__104270789.jpg"},"modified":"2018-10-16T11:22:26","modified_gmt":"2018-10-16T09:22:26","slug":"4__104270789","status":"inherit","type":"attachment","link":"https:\/\/www.seventure.fr\/en\/lnc-therapeutics-acquires-exclusive-license-for-the-christensenella-patent-from-cornell-university\/4__104270789\/","title":{"rendered":"4__104270789"},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false},"class_list":["post-3894","attachment","type-attachment","status-inherit","hentry"],"acf":[],"yoast_head":"\n